NANO MRNA Co.,Ltd. Logo

NANO MRNA Co.,Ltd.

Biotech IP generator developing and licensing mRNA therapeutics using proprietary delivery systems.

4571 | T

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
Japan
Address:
港区愛宕二丁目5番1号
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

NANO MRNA Co., Ltd. is a biotechnology company specializing in the research and development of mRNA-based therapeutics and other nucleic acid medicines. Operating under an "IP Generator" business model, the company functions as a platform connecting drug discovery seeds with medical and development needs. Its core strategy involves creating intellectual property for novel therapies and then licensing them out to pharmaceutical partners for further development and commercialization. NANO MRNA leverages proprietary Drug Delivery System (DDS) technologies to advance its pipeline, which includes candidates for indications such as osteoarthritis and glioblastoma. Formerly Nanocarrier Co., Ltd., the company has repurposed its extensive R&D experience to focus on mRNA drug discovery. In addition to its R&D activities, the company also markets co-developed pharmaceutical products.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-10-08 09:22
Prospectus
有価証券届出書(参照方式)
Japanese 205.3 KB
2025-07-18 08:30
Share Issue/Capital Change
臨時報告書
Japanese 28.4 KB
2025-07-01 08:30
Post-Annual General Meeting Information
臨時報告書
Japanese 25.9 KB
2025-06-30 08:33
Regulatory News Service
内部統制報告書-第29期(2024/04/01-2025/03/31)
Japanese 22.8 KB
2025-06-30 08:31
Regulatory News Service
確認書
Japanese 8.1 KB
2025-06-30 08:30
Annual Report
有価証券報告書-第29期(2024/04/01-2025/03/31)
Japanese 906.3 KB
2025-05-14 08:34
Regulatory News Service
臨時報告書
Japanese 18.7 KB
2025-02-14 07:38
Regulatory News Service
臨時報告書
Japanese 18.8 KB
2024-11-18 07:32
Regulatory News Service
臨時報告書
Japanese 18.6 KB
2024-11-14 07:03
Report Publication Announcement
確認書
Japanese 8.1 KB
2024-11-14 07:02
Interim Report
半期報告書-第29期(2024/04/01-2025/03/31)
Japanese 169.1 KB
2024-07-01 08:07
Regulatory News Service
臨時報告書
Japanese 22.2 KB
2024-06-28 08:06
Governance Information
内部統制報告書-第28期(2023/04/01-2024/03/31)
Japanese 22.1 KB
2024-06-28 08:05
Registration Form
確認書
Japanese 8.5 KB
2024-06-28 08:01
Annual Report
有価証券報告書-第28期(2023/04/01-2024/03/31)
Japanese 922.0 KB

Automate Your Workflow. Get a real-time feed of all NANO MRNA Co.,Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for NANO MRNA Co.,Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
1NKEMIA Logo
A tech group providing R&D, services, training, and investment for life sciences industries.
Spain IKM
AI-powered genome sequencing and reanalysis to diagnose rare diseases globally.
South Korea 394800
Develops antibody therapeutics and CAR-T for oncology and provides CRO services.
South Korea 174900
Clinical-stage biopharma developing therapeutics for oncology & viral infectious diseases.
South Korea 203400
ABL Bio Inc. Logo
Develops bispecific antibody therapies for oncology and neurodegenerative diseases.
South Korea 298380
Acticor Biotech Logo
Clinical-stage biopharma developing a first-in-class drug for thrombotic diseases like stroke.
France ALACT
Adecco Group AG Logo
Global talent solutions firm offering staffing, placement, career transition, and tech consulting.
Switzerland ADI1
ADforus Co., Ltd. Logo
Ad-tech firm with AI platforms for mobile marketing and publisher monetization solutions.
South Korea 397810
Adocia Logo
Biotech improving protein drug formulations for diabetes & obesity and developing cell therapies.
France ADOC
ad pepper media International N.V. Logo
Global performance marketing & audience targeting solutions for advertisers and agencies worldwide.
Germany APM

Talk to a Data Expert

Have a question? We'll get back to you promptly.